Annexon (ANNX) Other Non Operating Income (2019 - 2021)
Annexon's (ANNX) quarterly Other Non Operating Income came in at $82000.0 in Q3 2021, up 257.69% year-on-year from $22924.7 in Q3 2020, and up 3.8% quarter-over-quarter from $79000.0 in Q2 2021.
Annexon (ANNX) Other Non Operating Income (2019 - 2021) Analysis & Trends
Annexon's Other Non Operating Income history runs 3 years deep, the most recent figure standing at $82000.0 for Q3 2021.
- On a quarterly basis, Other Non Operating Income rose 257.69% year-over-year to $82000.0 in Q3 2021; TTM through Sep 2021 was $665000.0, a 2560.0% increase from a year earlier, with the FY2020 full-year figure at $426000.0, down 45.52% from the prior year.
- Other Non Operating Income climbed to $82000.0 in Q3 2021 per ANNX's latest filing, from $79000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $376000.0 in Q2 2019 and bottomed at -$52000.0 in Q3 2020.
- The 3-year median for Other Non Operating Income is $98500.0 (2020), against an average of $129000.0.
- Across the five-year window, Other Non Operating Income plunged 123.21% in 2020 and jumped 7800.0% in 2021, its largest moves.
- Year by year, Other Non Operating Income stood at -$39000.0 in 2019, then jumped by 1028.21% to $362000.0 in 2020, then slumped by 77.35% to $82000.0 in 2021.
- Per Business Quant, the three latest ANNX Other Non Operating Income figures stand at $82000.0 (Q3 2021), $79000.0 (Q2 2021), and $142000.0 (Q1 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Annexon | 1.02 Bn | 798.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 82,000.00 |
| Jun 30, 2021 | 79,000.00 |
| Mar 31, 2021 | 142,000.00 |
| Dec 31, 2020 | 362,000.00 |
| Sep 30, 2020 | -52,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 115,000.00 |
| Dec 31, 2019 | -39,000.00 |
| Sep 30, 2019 | 224,000.00 |
| Jun 30, 2019 | 376,000.00 |